Cambridge Bioscience, through our collaboration with ChanTest, offers access to GPCR screening and profiling services to angiotensin-like R1 and AT1:
Validated Assay/Platform: Calcium
Description: Two receptors for angiotensin II have been identified, AT1 and AT2 receptors. AT1 receptor antagonists have been shown to lower arterial blood pressure, reduce cardiac load, inhibit sympathetic activity and prevent cardiovascular hypertrophy.
Cambridge Bioscience, through our collaboration with ChanTest, offers access to both FLIPRTETRA® and FlexStation® 3 allowing you to select the right balance of speed, throughput and data quality to suit your needs.
To find out more about each of these platforms, please Click Here
Request A No Obligation Quote
To discuss a GPCR screening project, please contact our experienced team by Clicking Here